FILTER

Refine your search with the following facets to narrow down your results.

8 Current news of Gene Bridges

Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd.

02-Jun-2009 - Gene Bridges GmbH announced that Chugai Pharmaceutical Co., Ltd. of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET recombination technology from Gene Bridges. The Red/ET recombination technology, patented in Japan ...

chromosomes Daiichi Sankyo DNA cloning +2

Gene Bridges Licenses Recombineering Technology to Daiichi Sankyo Co., Ltd.

27-Mar-2009 - Gene Bridges GmbH announced that Daiichi Sankyo Co., Ltd. has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges. The Red/ET recombination technology, patented in Japan under the title "Novel DNA Cloning Method“, is a valued method for ...

chromosomes Daiichi Sankyo DNA cloning +2

Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology

01-Aug-2008 - Gene Bridges GmbH announced that it has been granted patents in Japan and in Mexico relating to the Company's recombineering technology. The Japanese Patent (No. 4139561) was entitled "Novel DNA Cloning Method" while the Mexican Patent (No. 252928) was entitled "Methods and compositions for ...

cloning DNA cloning patents

Gene Bridges licenses Red/ET Recombineering to Novozymes

23-Apr-2008 - Gene Bridges GmbH announced that Novozymes has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges. Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Novozymes for the purpose of genetically engineering ...

cloning license agreements microorganisms +1

Gene Bridges licenses Red/ET Recombineering to Genencor

02-Apr-2008 - Gene Bridges GmbH announced that Genencor International Inc. USA, a part of Danisco US Inc., has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges. Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to ...

biotechnology license agreements microorganisms +1

Mbiotech to distribute Gene Bridges Recombineering Technology in Korea

22-Feb-2008 - Gene Bridges GmbH announced that Mbiotech will distribute Gene Bridges' patented Red/ET recombination technology in Korea. Mbiotech was selected due to its expertise producing and marketing a wide range of molecular biology reagents. Under the terms of the agreement, Mbiotech will be the ...

acid purification molecular biology reagents

Gene Bridges granted Korean Patent for Recombineering Technology

10-Jan-2008 - Gene Bridges GmbH announced that it has been granted Korean Patent No. 10-0751587, entitled "Methods and compositions for directed cloning and sub-cloning using homologous recombination" by the Korean Patent Office. The patent broadly covers the major areas of Gene Bridges' RED/ET recombineering ...

cloning Life Sciences patents

Gene Bridges Announces Distribution Agreement with CAMBIO for Red/ET Recombination Kits

17-Feb-2004 - DRESDEN, Germany - Gene Bridges GmbH announced today, that CAMBIO Ltd., Cambridge, UK, has agreed to distribute Gene Bridges' Red/ET Recombination Kits in the United Kingdom & Ireland. "We are very pleased that a distribution organisation like CAMBIO, with such a strong market presence and ...

cloning systems biology United Kingdom